This information was published on 2025-12-01T08:31:34 for IP Right Registration Published.
| Field | Value |
| (210) | 2587850 (IR 1876036) |
| (220) |
18 Aug 2025
|
| (300) |
US, 24 Feb 2025, 99053158
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts. |
| (540) | ANKTIGEN |
| (550) | Word |
| (730) |
ImmunityBio, Inc.
|
Find out more about publications on the About page.